Meet this week’s #FridayFeature, Susie Park (she/her). Join us in celebrating Susie and all the remarkable women who continue to inspire and drive positive change in our world. Thank you, Susie! #AGCBio #EmployeeSpotlight #CoreValues #InternationalWomensDay

We are searching for a Financial Controller to join our team at our Copenhagen, Denmark site. Learn more about the position and apply now: hubs.ly/Q02pjmtl0 #AGCBio #CopenhagenJobs #FinanceJobs

AGC Biologics is proud to announce that our Milan site secured FDA clearance for the commercial manufacturing of Orchard Therapeutics' Lenmeldy™, a gene therapy for early-onset Metachromatic Leukodystrophy. Read the full press release here: hubs.ly/Q02pVfkd0

We are searching for a Senior Deviation Investigator to join our team at our Boulder, Colorado site. Learn more about the position and apply now: hubs.ly/Q02qQTxc0 #AGCBio #PharmaJobs #BoulderJobs #ColoradoJobs

Check out our recent interview with BioPharm Intl where our team dives into the biomanufacturing debate on single-use vs. stainless-steel bioreactors. Read the article to learn the benefits & limitations of each: hubs.ly/Q02sJs440 #biomanufacturing #bioreactors #CDMO

Today, AGC Biologics announced a strategic commercial collaboration with BioConnection, a specialized CMO focusing on aseptic filling of vials and syringes for clinical and commercial production. Read the full press release, here: hubs.ly/Q02y2tdj0

𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞: 𝐀𝐆𝐂 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐂𝐨𝐩𝐞𝐧𝐡𝐚𝐠𝐞𝐧 𝐃𝐨𝐮𝐛𝐥𝐞𝐬 𝐒𝐢𝐧𝐠𝐥𝐞-𝐔𝐬𝐞 𝐛𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫 𝐜𝐚𝐩𝐚𝐜𝐢𝐭𝐲! Our new manufacturing building in CPH is qualified and open for business. Read the full PR to learn more: hubs.ly/Q02zsLDX0

The grand opening of AGC Biologics' new state-of-the-art manufacturing facility at our Copenhagen campus, marks a significant milestone in the company's journey by more than doubling our single-use capacity. hubs.ly/Q02GyLvf0

AGC Biologics' Seattle Campus achieved a major regulatory milestone in March 2024, passing an FDA multi-product inspection, leading to the approval of two new products for commercial production. Read the full press release here: hubs.ly/Q02J7mbk0

AGC Biologics' Copenhagen Site has achieved a significant milestone with U.S. FDA approval for a biosimilar indicated for psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. Read the full press release here: hubs.ly/Q02MP9ts0

AGC Biologics has begun operations at our newly expanded state-of-the-art manufacturing facility in Copenhagen after receiving approval from the Danish Medicines Agency. The 19,000 m² building has doubled the site’s production capacity. Read the news: hubs.ly/Q02SSZp00

How can cell and gene therapy companies avoid costly delays and streamline vector development? The key lies in investing in a Gene of Interest (GOI) feasibility program before you go to GMP. Discover our new program - CMC Jumpstart™ hubs.ly/Q036f4TD0

Last month, we brought together industry leaders to envision the promising future of the biopharma sector at our annual CMO Summit in Seattle! Thank you to all participants for your invaluable insights; let's embrace the exciting opportunities ahead in biologics manufacturing!

AGC Biologics and AGC Pharm Chemicals received multiple awards at the 2025 CDMO Leadership Awards last week including special honors for “Best-in-Quality Quality Management Systems” (AGC Biologics) and “Best in Manufacturing Capabilities” (AGC Pharma Chemicals).

Did you miss this year's CDMO Leadership Awards? AGC Biologics was named a top CDMO in both Global Biologics and Global Cell and Gene Therapies and won Best in Quality Management Systems. Watch the video from the ceremony here: hubs.ly/Q03flqH10

Join us April 21st for the ADC Capacity Update from Outsourced Pharma for a global overview of the Proveo™ alliance, an ADC program that offers integrated and expedited CDMO services for antibody-drug conjugate products. Register here: hubs.ly/Q03hw94k0